| Q28910472 | A novel phosphorylation site, Serine 199, in the C-terminus of cardiac troponin I regulates calcium sensitivity and susceptibility to calpain-induced proteolysis |
| Q34277120 | Activation of m-calpain (calpain II) by epidermal growth factor is limited by protein kinase A phosphorylation of m-calpain |
| Q37224663 | Alpha 1-Antichymotrypsin, an Inflammatory Protein Overexpressed in the Brains of Patients with Alzheimer's Disease, Induces Tau Hyperphosphorylation through c-Jun N-Terminal Kinase Activation |
| Q42587729 | Biliverdin reductase: more than a namesake - the reductase, its Peptide fragments, and biliverdin regulate activity of the three classes of protein kinase C |
| Q36684722 | CREB regulates the expression of neuronal glucose transporter 3: a possible mechanism related to impaired brain glucose uptake in Alzheimer's disease |
| Q42527842 | Ca(2+)-mediated phosphorylation and proteolysis activity associated with the cytoskeletal fraction from cerebral cortex of rats |
| Q36586276 | Calpain and synaptic function |
| Q26801541 | Clearance systems in the brain-implications for Alzheimer disease |
| Q48172695 | Comparison of the phosphorylation of microtubule-associated protein tau by non-proline dependent protein kinases |
| Q52510992 | Compromised mitochondrial function results in dephosphorylation of tau through a calcium-dependent process in rat brain cerebral cortical slices. |
| Q24630927 | Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century |
| Q48139851 | Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice. |
| Q42123152 | Disruption of protein kinase A interaction with A-kinase-anchoring proteins in the heart in vivo: effects on cardiac contractility, protein kinase A phosphorylation, and troponin I proteolysis. |
| Q37280507 | Evidence for prion-like mechanisms in several neurodegenerative diseases: potential implications for immunotherapy |
| Q41603886 | Expression and phosphorylation of a three-repeat isoform of tau in transfected non-neuronal cells |
| Q35565682 | Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation |
| Q33799921 | Human biliverdin reductase suppresses Goodpasture antigen-binding protein (GPBP) kinase activity: the reductase regulates tumor necrosis factor-alpha-NF-kappaB-dependent GPBP expression |
| Q40744670 | Inhibition of JNK by a peptide inhibitor reduces traumatic brain injury-induced tauopathy in transgenic mice |
| Q34995075 | Intracellular A-beta amyloid, a sign for worse things to come? |
| Q64998890 | Involvement of calpain in the neuropathogenesis of Alzheimer's disease. |
| Q36236501 | Mitotic mechanisms in Alzheimer's disease? |
| Q42114191 | Modulation of the phosphorylation state of tau in situ: the roles of calcium and cyclic AMP. |
| Q50504229 | Multiple forms of phosphatase from human brain: isolation and partial characterization of affi-gel blue nonbinding phosphatase activities. |
| Q49160674 | Non-proline-dependent protein kinases phosphorylate several sites found in tau from Alzheimer disease brain |
| Q33983175 | Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments |
| Q40950486 | PEST sequences in calmodulin-binding proteins. |
| Q40238615 | Phosphorylation inhibits turnover of the tau protein by the proteasome: influence of RCAN1 and oxidative stress |
| Q37349336 | Phosphorylation of prion protein at serine 43 induces prion protein conformational change |
| Q37229319 | Physiological regulation of tau phosphorylation during hibernation |
| Q33189095 | Poliovirus infection results in structural alteration of a microtubule-associated protein |
| Q52196473 | Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5. |
| Q48790449 | Protein kinase C and calcium/calmodulin-dependent protein kinase II phosphorylate three-repeat and four-repeat tau isoforms at different rates |
| Q41896600 | Pseudohyperphosphorylation causing AD-like changes in tau has significant effects on its polymerization |
| Q24530141 | Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration |
| Q33559303 | Roles of tau protein in health and disease |
| Q34995112 | Tau and axonopathy in neurodegenerative disorders |
| Q24312948 | Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis |
| Q41945501 | Tau pathology: predictive diagnostics, targeted preventive and personalized medicine and application of advanced research in medical practice |
| Q42059767 | Tau protein is phosphorylated by cyclic AMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase II within its microtubule-binding domains at Ser-262 and Ser-356. |
| Q24643397 | The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states |
| Q43892348 | The rate of Tau synthesis is differentially regulated during postnatal development in mouse cerebellum. |
| Q37765632 | The role of tau in Alzheimer's disease and related disorders |
| Q41327023 | The role of tau phosphorylation in transfected COS-1 cells |
| Q35035648 | Truncation and activation of GSK-3β by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer's disease |